Making Sense of Convalescent Plasma

Scientists across the world sprang into action when it was evident we had a pandemic on our hands. In the race to help prevent hospitalizations and deaths, researchers turned to convalescent plasma as a treatment candidate against COVID-19.While doctors and medical professionals have since turned to other treatments and strategies to curb the spread of COVID-19, many were left wondering, “what happened with convalescent plasma?”In today’s episode, Dr. Shmuel Shoham of Johns Hopkins University joins our hosts to discuss just that. Dr. Shoham is an infectious disease specialist who primarily worked with transplant patients before the pandemic. He was among the countless medical professionals who grew increasingly concerned about the pandemic’s impact on patients with comorbidities.Tune in with Dr. Jim McDonald and Dr. Philip Chan to learn about what happened with this experimental treatment, and what the data and science say about its future.